Production of an anti-angiogenic factor sFLT1 is suppressed via promoter hypermethylation of FLT1 gene in choriocarcinoma cells.

Abstract

BACKGROUND:

Soluble Fms-like tyrosine kinase-1 (sFLT1) as an anti-angiogenic factor is abundantly expressed in placental trophoblasts. Choriocarcinoma, a malignant tumor derived from trophoblasts, is known to be highly angiogenic and metastatic. However, the molecular mechanism underlying angiogenesis in choriocarcinoma pathogenesis remains unclear. We aimed to investigate the mRNA expression and DNA methylation status of the FLT1 gene in human choriocarcinoma cells and trophoblast cells.

METHODS:

qRT-PCR, Western blotting and ELISA were conducted to evaluate the mRNA and protein expression levels of sFLT1. 5-aza-2'-deoxycytidine (5azadC) treatment and bisulfite sequencing were used to study the FLT1 gene promoter methylation. The effect of sFLT1 on choriocarcinoma growth and angiogenesis was evaluated in a xenograft mouse model.

RESULTS:

Expression of the FLT1 gene was strongly suppressed in choriocarcinoma cell lines compared with that in the primary trophoblasts. Treatment of choriocarcinoma cell lines with 5azadC, a DNA methyltransferase inhibitor, markedly increased in mRNA expression of three FLT1 splice variants and secretion of sFLT1 proteins. Bisulfite sequencing revealed that the CpG hypermethylation was observed at the FLT1 promoter region in choriocarcinoma cell lines and a human primary choriocarcinoma tissue but not in human trophoblast cells. Interestingly, in 5azadC-treated choriocarcinoma cell lines, sFLT1 mRNA expression and sFLT1 production were further elevated by hypoxic stimulation. Finally, as expected, sFLT1-expressing choriocarcinoma cells implanted into nude mice showed significantly slower tumor growth and reduced microvessel formation compared with GFP-expressing control choriocarcinoma cells.

CONCLUSIONS:

Inhibition of sFLT1 production by FLT1 silencing occurs via the hypermethylation of its promoter in choriocarcinoma cells. The stable expression of sFLT1 in choriocarcinoma cells resulted in the suppression of tumor growth and tumor vascularization in vivo. We suggest that the FLT1 gene may be a cell-type-specific tumor suppressor in choriocarcinoma cells.

• Authors: Tadashi Sasagawa, Atsushi Jinno-Oue, Takeshi Nagamatsu, Kazuki Morita, Tetsushi Tsuruga, Mayuyo Mori-Uchino, Tomoyuki Fujii, Masabumi Shibuya
• Journal: BMC cancer (BMC Cancer) Vol. 20 Issue 1 Pg. 112 (Feb 10 2020) ISSN: 1471-2407 [Electronic] England
• PMID: 32041578 (Publication Type: Journal Article)

Chemical References

• Protein Isoforms
• RNA, Messenger
• Vascular Endothelial Growth Factor A
• FLT1 protein, human
• Vascular Endothelial Growth Factor Receptor-1

Topics

• Animals
• Cell Line, Tumor
• Cell Transformation, Neoplastic (genetics, metabolism)
• Choriocarcinoma (genetics, metabolism, pathology)
• CpG Islands
• DNA Methylation
• Disease Models, Animal
• Female
• Gene Expression Regulation, Neoplastic
• Humans
• Hypoxia (genetics, metabolism)
• Mice
• Neovascularization, Pathologic (genetics, metabolism)
• Promoter Regions, Genetic
• Protein Isoforms
• RNA Splicing
• RNA, Messenger (genetics, metabolism)
• Vascular Endothelial Growth Factor A (genetics)
• Vascular Endothelial Growth Factor Receptor-1 (biosynthesis, genetics)
• Xenograft Model Antitumor Assays